Protection and antibody levels 35 years after primary series with hepatitis B vaccine and response to a booster dose.
Michael G BruceDana BrudenDebby HurlburtJulie MorrisSara BresslerGail ThompsonDanielle LecyKaren RudolphLisa BulkowThomas HennessyBrenna C SimonsMark K WengNoele NelsonBrian J McMahonPublished in: Hepatology (Baltimore, Md.) (2022)
Based on anti-HBs level ≥10 mIU/ml at 35 years and a 73.7% booster dose response, we estimate that 86% of participants had evidence of protection 35 years later. Booster doses are not needed in the general population at this time.
Keyphrases